Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F3GL
|
|||
| Former ID |
DNCL003028
|
|||
| Drug Name |
Vacc-4x
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Human immunodeficiency virus-1 infection [ICD-11: 1C62; ICD-10: B20-B24] | Phase 2 | [1] | |
| Company |
Bionor Pharma
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Human immunodeficiency virus Capsid p24 (HIV p24) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01712256) Re-boosting of HIV-1 Infected Subjects With Vacc-4x. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Bionor Pharma. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.